Theratechnologies' Novel AIDS Drug Filed In US
Theratechnologies' partner TaiMed Biologics is seeking US approval of its novel antibody treatment for multidrug resistant HIV, ibalizumab, which offers a new therapy avenue for the increasing number of HIV patients who have worked through existing treatment options.
